Corcept Therapeutics (CORT) cash on hand

Cash · fiscal 2025
$372.15M

Corcept Therapeutics (CORT) held cash of $372.15M at the end of fiscal 2025 (December 31, 2025). That is 2.9% lower than the $383.33M of fiscal 2024. Figures as of 18 Nov 2026, 00:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$372.15M
Change on fiscal 2024
−2.9%
Highest on record
$431.67Mfiscal 2022
Lowest on record
$368.22Mfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Corcept Therapeutics cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $431.67M in fiscal 2022 and the lowest $368.22M in fiscal 2023.

History · 4 fiscal years

Cash by fiscal year

Corcept Therapeutics cash on hand, year by year

Corcept Therapeutics (CORT) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$372.15M 2.9% down
2024$383.33M 4.1% up
2023$368.22M 14.7% down
2022$431.67M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of Corcept Therapeutics and comparable companies
CompanyCashFiscal year
10x Genomics TXG$523.41M2025
HealthEquity HQY$318.93M2026
Corcept Therapeutics CORT$372.15M2025
Rhythm Pharmaceuticals RYTM$388.95M2025
Alkermes ALKS$588.22M2025
PACS Group PACS$197.02M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CORT

Corcept Therapeutics, figure by figure

Corcept Therapeutics (CORT) overview: price, valuation and scorecardAll health care companies by market value

Corcept Therapeutics cash on hand: questions and answers

How much cash does Corcept Therapeutics have?

Corcept Therapeutics (CORT) held cash of $372.15M at the end of fiscal 2025 (December 31, 2025). That is 2.9% lower than the $383.33M of fiscal 2024.

What are the highest and lowest cash figures on record for Corcept Therapeutics?

Across the 4 fiscal years on record (2022–2025), the highest was $431.67M in fiscal 2022 and the lowest $368.22M in fiscal 2023.

How is Corcept Therapeutics's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corcept Therapeutics (CORT) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/CORT/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.